Korean Circ J.  2010 Nov;40(11):550-551. 10.4070/kcj.2010.40.11.550.

Two Problems With Analyzing Natriuretic Peptide Levels: Obesity and Acute Myocardial Infarction

• Ahn MS
• Yoo BS

• KMID: 1826172
• DOI: http://doi.org/10.4070/kcj.2010.40.11.550

Abstract

No abstract available.

MeSH Terms

Myocardial Infarction
Obesity

Reference

1. Maisel A, Mueller C. North American B-Type Natriuretic Peptide (BNP) Consensus Working Group. Congest Heart Fail. 2008. 14:4 Suppl 1. 4.

2. Bettencourt P, Januzzi JL Jr. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol. 2008. 101:67–71.

3. Eggers KM, Lagerqvist B, Venge P, Wallentin C, Lindahl B. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2009. 54:357–364.

4. Bayes-Genis A, DeFilippi C, Januzzi JL Jr. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol. 2008. 101:89–94.

5. Horio T, Shimada K, Kohno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J. 1993. 126:293–299.

6. Choi SG, Jeong MH, Ahn Y, et al. Relationship between obesity and N-terminal brain natriuretic peptide level as a prognostic value after acute myocardial infarction. Korean Circ J. 2010. 40:558–564.

7. Shah K, Terracciano GJ, Jiang K, Maisel AS, Fitzgerald RL. Comparability of results between point-of-care and automated instruments to measure B-type natriuretic peptide. West J Emerg Med. 2010. 11:44–48.

8. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol. 2006. 47:85–90.

9. Tapanainen JM, Lindgren KS, Makikallio TH, Vuolteenaho O, Leppaluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2004. 43:757–763.

10. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008. 10:824–839.

11. Choe HM, Yoo BS, Ryu HY, et al. The early changing pattern of the B-Type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction. Korean Circ J. 2006. 36:526–534.